Guided Therapeutics Inc (GTHP) Financial Statements (2024 and earlier)

Company Profile

Business Address 5835 PEACHTREE CORNERS EAST
PEACHTREE CORNERS, GA 30092
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,313643182899 1
Cash and cash equivalents2,313643182899 1
Receivables6172    
Inventory, net of allowances, customer advances and progress billings54857160548114265
Inventory54857160548114265
Other current assets137377857069111
Other undisclosed current assets  (126)2413133
Total current assets:3,0041,6378961,030196380
Noncurrent Assets
Operating lease, right-of-use asset303372453132
Property, plant and equipment42141 2149
Other noncurrent assets1717    
Other undisclosed noncurrent assets    181960
Total noncurrent assets:36240345415040109
TOTAL ASSETS:3,3662,0401,3501,180236489
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,4334,7407,1337,3757,3199,679
Interest and dividends payable6101,719120120291
Employee-related liabilities  1,1231,0302,122
Accounts payable2,1862,3622,4192,8973,0133,019
Accrued liabilities1,2471,7682,9953,2353,1564,247
Deferred revenue50933742 
Debt132136731,3351,0801,874
Due to related parties4087116136  
Other undisclosed current liabilities7553941,5983,5642,593376
Total current liabilities:4,8695,6948,96212,41010,99211,929
Noncurrent Liabilities
Long-term debt and lease obligation 1,04632541544340 
Long-term debt, excluding current maturities 1,046 2315340 
Liabilities, other than long-term debt334624625569340 
Due to related parties83592600569340 
Operating lease, liability24632539229
Derivative instruments and hedges, liabilities 53225   
Other undisclosed noncurrent liabilities 8422,2035,0924,3887,962
Total noncurrent liabilities:1,3801,7913,2435,7055,0687,962
Total liabilities:6,2497,48512,20518,11516,06019,891
Equity
Equity, attributable to parent, including:(2,883)(5,445)(10,855)(16,935)(15,824)(19,402)
Common stock3,4373,4033,4033,3942,877791
Treasury stock, value(132)(132)(132)(132)(132)(132)
Common stock, value, subscriptions  351  692276
Additional paid in capital138,090126,800123,109118,552118,259117,416
Accumulated deficit(147,359)(142,387)(139,956)(139,555)(137,634)(138,533)
Other undisclosed equity, attributable to parent 3,0816,5202,721806114780
Other undisclosed equity      
Total equity:(2,883)(5,445)(10,855)(16,935)(15,824)(19,402)
TOTAL LIABILITIES AND EQUITY:3,3662,0401,3501,180236489

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1381102365718
Other income16507271485418
Cost of revenue(81)  (70)(89)(530)
Cost of goods and services sold(81)    (530)
Other undisclosed gross profit  (61)41  226
Gross profit:(68)20143(34)(32)(286)
Operating expenses(3,265)(2,382)(1,195)(903)(1,516)(2,835)
Operating loss:(3,333)(2,362)(1,052)(937)(1,548)(3,121)
Nonoperating income (expense)(1,008)292773(984)3,209(7,575)
Debt instrument, convertible, beneficial conversion feature     645 
Other nonoperating income (expense)(1,008)292773(984)2,564(7,575)
Interest and debt expense(655)578(296)(1,412)1,039(1,106)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes655(578)    
Income (loss) from continuing operations before equity method investments, income taxes:(4,341)(2,070)(575)(3,333)2,700(11,802)
Other undisclosed income (loss) from continuing operations before income taxes   2961,412(1,684)1,106
Income (loss) from continuing operations:(4,341)(2,070)(279)(1,921)1,016(10,696)
Income (loss) before gain (loss) on sale of properties:(2,070)(279)(1,921)1,016(10,696)
Other undisclosed net income      
Net income (loss):(4,341)(2,070)(279)(1,921)1,016(10,696)
Other undisclosed net loss attributable to parent      
Net income (loss) attributable to parent:(4,341)(2,070)(279)(1,921)1,016(10,696)
Preferred stock dividends and other adjustments   (122) (116)(278)
Other undisclosed net loss available to common stockholders, basic(631)(361)    
Net income (loss) available to common stockholders, diluted:(4,972)(2,431)(401)(1,921)900(10,974)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(4,341)(2,070)(279)(1,921)1,016(10,696)
Comprehensive income (loss), net of tax, attributable to parent:(4,341)(2,070)(279)(1,921)1,016(10,696)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: